louisakewell, Author at European Medical Journal - Page 59 of 153

Continue
1 Mins
5th July 2016

Introducing EMJ Nephrology 4.1

United Kingdom, July 5, 2016: Welcome to the 2016 edition of EMJ Nephrology, which provides extensive coverage of research and developments across the…
3 Mins
5th July 2016

Anti-Interleukin-1 Alpha Antibody MABp1 Improves Outcomes Significantly over Placebo

Barcelona-Lugano, July 02, 2016 – A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and…
1 Mins
30th June 2016

Introducing EMJ Interventional Cardiology 4.1

United Kingdom, June 30, 2016: Welcome to the 2016 edition of EMJ Interventional Cardiology, an assortment of the latest news, research, and opinions…
4 Mins
30th June 2016

Regorafenib Shows Significant Survival Gains in Refractory Liver Cancer

Barcelona-Lugano, June 30, 2016 – Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients…
3 Mins
30th June 2016

Chemoradiotherapy after Surgery for Gastric Cancer Shows Similar Outcomes to Post-Operative Chemotherapy

Barcelona-Lugano, June 30, 2016 – Post-operative treatment intensification with chemoradiotherapy does not achieve better outcomes when compared to…
4 Mins
29th June 2016

Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition

June 29, 2016 – Anti-PD-L1 immunotherapy may achieve a response in patients with microsatellite-stable metastatic colorectal cancer if combined with…
3 Mins
22nd June 2016

IBD Drug Availability Putting Children at Risk of Lifelong Health Complications

June 21, 2016 – To halt the health risks for children and improve outcomes in the future, IBD experts across Europe are calling for an urgent increase in…
1 Mins
22nd June 2016

Richard Wolf Presents Its Profile at the 24th International Congress of the E.A.E.S in Amsterdam

June 16, 2016 – Particularly in contemporary medicine, the importance of efficient processes is steadily increasing on account of the rising pressure…
1 Mins
22nd June 2016

iVascular Completes Recruitment of Patients for Its ANCHOR Clinical Trial of the Sirolimus Eluting Stent ANGIOLITE

May 19, 2016 – Coordinated by PI Dr. Josep Rodés-Cabau from Quebec Heart and Lung Institute, the objective of ANCHOR clinical trial is to perform a…
1 Mins
22nd June 2016

iVascular Receives CE Mark Approval for LUMINOR 18 Drug Eluting Balloon

May 16, 2016 – LUMINOR 18, which is 0.018 Guide Wire compatible, is added to the existing LUMINOR range (Luminor14 and Luminor35), to offer the only…